You have 9 free searches left this month | for more free features.

childhood extracranial germ cell tumor

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Duarte, California
  • +6 more
Jan 18, 2023

COVID Vaccine Immunity in Kidney Transplant Recipients

Withdrawn
  • End Stage Renal Disease
  • Kidney Transplant; Complications
  • Coronavirus (COVID-19) SARS-CoV-2 inSIGHTâ„¢ T Cell Immunity Test
  • (no location specified)
Oct 25, 2022

Hematopoietic Stem Cell Transplantation (HSCT), Acute GVH Disease Trial in Boston (Vancomycin-polymyxin B)

Active, not recruiting
  • Hematopoietic Stem Cell Transplantation (HSCT)
  • Acute GVH Disease
  • Vancomycin-polymyxin B
  • Boston, Massachusetts
  • +1 more
Jan 28, 2022

Chemo-induced Nausea and Vomiting Trial in Chicago (Granisetron Transdermal Patch, Intravenous Dexamethasone, Ondansetron)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Granisetron Transdermal Patch
  • +2 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Jun 7, 2022

Solid Tumor, Adult Lymphoma Trial (HLX51)

Not yet recruiting
  • Solid Tumor, Adult Lymphoma
  • (no location specified)
Mar 15, 2023

Solid Tumors Trial in Belgium, France, United States (INCB057643, Gemcitabine, Paclitaxel)

Terminated
  • Solid Tumors
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

Active, not recruiting
  • Human Papillomavirus-16 Positive
  • +20 more
  • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
  • Durvalumab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2022

Behavior Disorders in Children Trial in Rawalpindi (child-Parent Relationship Therapy (CPRT))

Recruiting
  • Behavior Disorders in Children
  • child-Parent Relationship Therapy (CPRT)
  • Rawalpindi, Pakistan
    Tayyaba Hanif
Oct 10, 2023

Dedifferentiated Liposarcoma Trial in Worldwide (Cabazitaxel)

Completed
  • Dedifferentiated Liposarcoma
  • Antwerpen, Belgium
  • +10 more
Sep 10, 2021

Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Multiple Dose Insulin Therapy
  • Personalized treatment
  • (no location specified)
Nov 18, 2023

X-linked Adrenoleukodystrophy Trial in Leipzig (SMART-ALD, Waiting list)

Recruiting
  • X-linked Adrenoleukodystrophy
  • SMART-ALD
  • Waiting list
  • Leipzig, Saxony, Germany
  • +1 more
Aug 16, 2022

Advanced Malignant Tumors Trial in Guangzhou, Hangzhou (TQB3617)

Recruiting
  • Advanced Malignant Tumors
  • Guangzhou, Guangdong, China
  • +1 more
Feb 11, 2022

Long Non-coding RNA in Process of Epithelial-mesenchymal

Active, not recruiting
  • Periodontal Disease, AVDC Stage 3and 4
  • +2 more
  • periodontitis challenge
  • Baghdad, Iraq
    saif mohammed T AL Mufti
Aug 8, 2023

Child Behavior, Child Behavior Problem, Child Behavior Disorders Trial (Cultural Pride Reinforcement for Early School Readiness,

Not yet recruiting
  • Child Behavior
  • +3 more
  • Cultural Pride Reinforcement for Early School Readiness
  • Reach Out and Read
  • (no location specified)
Oct 12, 2023

COVID-19 Trial in Barranquilla (Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron

Not yet recruiting
  • COVID-19
  • Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Barranquilla, Colombia
    Clinica de la Costa
Jun 23, 2022

Colon Cancer Stage III Trial in Sadat City (ChlorproMAZINE 50 MG, Control)

Not yet recruiting
  • Colon Cancer Stage III
  • Sadat City, Menoufia, Egypt
    Faculty of Pharmacy, University of Sadat city
Jun 22, 2022

Non-Squamous Non Small Cell Lung Cancer Trial in Changsha (Anlotinib and Docetaxel)

Recruiting
  • Non-Squamous Non Small Cell Lung Cancer
  • Anlotinib and Docetaxel
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 1, 2022

Lung Cancer, Cancer of Lung, Pulmonary Cancer Trial in Atlanta (Arsenic Trioxide)

Completed
  • Lung Cancer
  • +4 more
  • Arsenic Trioxide
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Feb 15, 2021

Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pexastimogene Devacirepvec (Pexa-Vec)
  • Cemiplimab
  • Irvine, California
  • +17 more
Oct 26, 2022

Rheumatoid Arthritis Trial in Montpellier (Blood sampling)

Not yet recruiting
  • Rheumatoid Arthritis
  • Blood sampling
  • Montpellier, France
    Centre Hospitalier Universitaire de Montpellier
Mar 24, 2023

Breast Carcinoma, Digestive System Tumor, Malignant Brain Tumor Trial in Scottsdale, Jacksonville (Biospecimen Collection,

Active, not recruiting
  • Breast Carcinoma
  • +10 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Feb 17, 2022

Recurrent Adult Soft Tissue Sarcoma Trial in Los Angeles (procedure, radiation, other)

Recruiting
  • Recurrent Adult Soft Tissue Sarcoma
  • Conventional Surgery
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 2, 2022

Cancer, Breast Cancer, Colorectal Cancer Trial in Chapel Hill (Weekly Survey)

Not yet recruiting
  • Cancer
  • +2 more
  • Weekly Survey
  • Chapel Hill, North Carolina
    University of North Carolina
Oct 17, 2023

Sickle Cell Disease Trial in Dallas (Single Session Problem-Solving Intervention)

Completed
  • Sickle Cell Disease
  • Single Session Problem-Solving Intervention
  • Dallas, Texas
    Children's Medical Center
Mar 18, 2022